Dr Steven Peskin on Reforms Needed to Incentivize Value-Based Contracts

October 27, 2021 10:00pm

Some policy reforms can help incentivize more use of value-based contracts, but overall an area that needs more work is value-based contracts with pharmaceutical companies, said Steven Peskin, MD, executive director, director of population health, Horizon Blue Cross Blue Shield of New Jersey.

Lance Grady Discusses Continued At-Home Administration of Specialty Pharmaceuticals
Unraveling the Growing Influence of Consolidation, 340B, and Industry in Specialty Pharmacy
Patients in Risankizumab Phase 2a Trial Saw Some Asthma Symptoms Increase
Obesity Shown to Adversely Influence Heart Health Prior to Symptom Onset